Receptor Therapeutics Inc.

 

Receptor Therapeutics Inc. is a green-field start-up company seeking to in-license two or three late pre-clinical or early clinical development candidates in oncology or infectious disease.   Receptor has assembled a seasoned management, experienced Board and an outstanding team of drug development advisors to direct its programs. The Company is supported by deep-pocketed venture capital investors.  Receptor is seeking opportunities that can be rapidly developed to the next level of value.

Joseph Elliot, Ph.D.
President & CEO
416-673-8153
jelliot@receptor.ca
www.receptor.ca

 
 
Get More From MaRS   MaRS NEWSLETTERS
Facebook Twitter Vimeo Flickr

MaRS Charitable Registration Number
876682717 RR0001

Please enter your email address to subscribe to our newsletter